Legitimate Ibogaine

About

Legitimate Ibogaine is a new independent information company helping people researching ibogaine make sense of ibogaine, focused on evidence, safety, legality and practical questions.

We publish clear, evidence-first writing for people who are researching ibogaine, whether they are patients, clinicians, or curious family members. Our aim is to describe how information is gathered and why certain sources are used, not to offer treatment or medical advice.

Our editorial approach

How we source and vet information

Legitimate Ibogaine draws on primary registries, peer-reviewed literature, and official guidance when available. Where registry or literature data is scarce we note uncertainty rather than fill gaps with speculation; that approach aligns with best practices used by medical libraries and university evidence services such as the National Library of Medicine on nlm.nih.gov.

When summarizing safety or legal frameworks we consult authoritative summaries and regulatory sites; for example, high-level overviews of controlled-substance scheduling are cross-checked with legal references like justice.gov.

What we cover

Our editorial remit focuses on evidence, safety, legality and practical questions about ibogaine for people researching ibogaine. We do not offer clinical services; instead we provide structured information and pointers to primary sources so readers can make informed decisions.

Trusted registries

When possible we reference clinical trial registries and published datasets rather than anecdotal posts; this mirrors transparent evidence practices described on platforms like Wikipedia's evidence-based practice.

Safety & legality

We summarize safety considerations and legal frameworks and link to primary regulatory sources where possible. For readers seeking comparative legal context, we point to official government portals rather than secondary summaries.

Editorial principles

  • Independence. We keep editorial decisions separate from clinics or commercial providers.
  • Plain language. We write so people researching ibogaine can understand tradeoffs and evidence without jargon.
  • Evidence-first. Claims are tied to sources; uncertainty is acknowledged.
  • Audience-focused. Our structure and FAQs are designed for people researching ibogaine, not clinicians or vendors.
  • No fabricated credentials. We do not invent staff titles, clinic affiliations, or awards.

These principles guide how we edit and update content; they are consistent with editorial standards used across independent health information initiatives and academic centers.

Who this is for

We build resources for people researching ibogaine — whether you are reading to understand safety screening, to review the clinical evidence, or to separate myths from reliable findings. If you arrived via a search or a referral, the site architecture and our services page explain how to find focused materials; for a concise guide to practical site navigation see our services page where editorial guides and curated explainers are signposted.

How to use this page

This About page explains our mission and methods. To return to topical entry points, follow the site navigation or the homepage sentence that links readers back to the main hub at the root of the site — our homepage offers a clear path to topical sections and topical collections.

Independent by design

Legitimate Ibogaine is an independent information resource. It is not a clinic, medical provider, or licensed treatment center, and its content is not medical or legal advice. Readers should consult licensed professionals for personal medical or legal questions.

For readers seeking technical background about how ibogaine is discussed in scientific and regulatory spaces, we sometimes point to external domain hubs such as cdc.gov when describing general approaches to evidence and safety—these citations support editorial transparency rather than clinical guidance.

Frequently asked questions

Why was Legitimate Ibogaine created?

Our mission is to help people researching ibogaine make sense of the available information by emphasizing evidence, safety, legality and practical questions; we do not provide treatment. Readers who want a topical entry can follow the contextual hub on the homepage that links to focused sections at the root of the site.

How do you decide which sources to trust?

We prioritize primary literature, clinical registries, and official guidance when available, and we document uncertainty when sources conflict. For standard guidance on evaluating evidence quality, see general frameworks such as those outlined by academic institutions like Harvard T.H. Chan School of Public Health which describe transparent evidence assessment approaches.

Is Legitimate Ibogaine affiliated with clinics or providers?

No. We are independent. We explicitly avoid clinic endorsements and do not list treatment providers as part of our editorial content; our footer reiterates this disclosure and explains the site's limits as an information resource.